GLP-1 receptor agonist medications are typically considered for type 2 diabetes when other treatments are ineffective or inappropriate, particularly if you have a BMI 35 kg/m with weight-related complications
In the world of performance enhancement and anti-aging medicine, peptides have emerged as one of the most effective and targeted tools for growth, recovery, and body composition
Compared with untreated individuals, those receiving GLP-1 therapy showed lower levels of pro-inflammatory cytokines (IL-6, TNF-, IL-12), higher levels of IL-10, reduced expression of endothelial adhesion molecules (ICAM-1, VCAM-1), and decreased leukocyte rolling and adhesion along the vascular endothelium [15]
Keep in a cool, dry place (up to 25C), out of sight and reach of young children
Circulation 127 , 7485 (2013)